Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Prostacyclin measurement |
Has measured component (attribute) |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Prostacyclin measurement |
Component |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Product containing prostacyclin PGI2 (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Product containing epoprostenol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Product containing iloprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Iloprost 100micrograms/mL infusion concentrate 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
époprosténol 500 microgrammes, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Iloprost 10mcg/mL nebulizer solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Epoprostenol 1.5mg powder and solvent for infusion vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Epoprostenol sodium 1.5mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Epoprostenol sodium 0.5mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|
Prostacyclin PGI2 (substance) |
Is a |
False |
Prostaglandin PGI>2< |
Inferred relationship |
Some |
|